Original contribution
Chemical exchange saturation transfer MR imaging of articular cartilage glycosaminoglycans at 3 T: Accuracy of B0 Field Inhomogeneity corrections with gradient echo method

https://doi.org/10.1016/j.mri.2013.07.009Get rights and content

Abstract

Glycosaminoglycan Chemical Exchange Saturation Transfer (gagCEST) is an important molecular MRI methodology developed to assess changes in cartilage GAG concentrations. The correction for B0 field inhomogeneity is technically crucial in gagCEST imaging. This study evaluates the accuracy of the B0 estimation determined by the dual gradient echo method and the effect on gagCEST measurements. The results were compared with those from the commonly used z-spectrum method. Eleven knee patients and three healthy volunteers were scanned. Dual gradient echo B0 maps with different ∆TE values (1, 2, 4, 8, and 10 ms) were acquired. The asymmetry of the magnetization transfer ratio at 1 ppm offset referred to the bulk water frequency, MTRasym(1 ppm), was used to quantify cartilage GAG levels. The B0 shifts for all knee patients using the z-spectrum and dual gradient echo methods are strongly correlated for all ∆TE values used (r = 0.997 to 0.786, corresponding to ∆TE = 10 to 1 ms). The corrected MTRasym(1 ppm) values using the z-spectrum method (1.34% ± 0.74%) highly agree only with those using the dual gradient echo methods with ∆TE = 10 ms (1.72% ± 0.80%; r = 0.924) and 8 ms (1.50% ± 0.82%; r = 0.712). The dual gradient echo method with longer ∆TE values (more than 8 ms) has an excellent correlation with the z-spectrum method for gagCEST imaging at 3 T.

Introduction

Osteoarthritis (OA) is one of the leading causes of chronic disability and characterized by the gradual breakdown and eventual loss of joint cartilage [1], [2], [3]. This disease is a significant public health problem. Using prevalence estimates, the National Arthritis Data Workgroup reported that OA affects nearly 27 million Americans or 12.1% of the adult population in 2005 [4], [5]. While there are no recent estimates of medical costs for OA, 2003 US medical expenditures attributable to arthritis and other rheumatic conditions aggregated $81 billion, of which OA is likely to account for a large proportion [6].

X-ray can visualize OA changes of the bone, but it has limited ability to assess soft-tissue involvement. CT is better at providing assessment of soft-tissue and osseous changes, but is not very sensitive for evaluating the extent and severity of OA [7]. Magnetic resonance imaging (MRI) has been advancing over the past two decades with the development of cartilage-specific sequences and is unique for assessing meniscal and ligamentous disease related to OA, providing clinicians with more information regarding the health and status of the cartilage in situ [8], [9], [10], [11]. In addition to the commonly used morphological sequences, such as proton density-, T1- and T2-weighted, multiple advanced MRI imaging methods, including T [12], [13] and 23Na MRI [14], [15], have been developed to quantify regional variations in cartilage within its micro-architecture. Chemical exchange saturation transfer (CEST) MRI has been developed as a molecular MRI methodology which detects endogenous macromolecules indirectly through chemical exchange and cross-relaxation with bulk water protons [16], [17], [18], [19], [20], [21]. The extent of contrast depends on the concentration of available macromolecules. gagCEST-MRI appears to be capable of assessing glycosaminoglycans (GAGs) to detect early articular cartilage degeneration and glycosaminoglycan concentration changes in the intervertebral disc [22], [23], [24], [25], [26]. OA was reported to be associated with a decrease in GAG concentration before the observable joint space thinning or morphological changes in the cartilage matrix (Outerbridge grade II or more) [27], [28]. Thus, gagCEST-MRI can be performed as a useful tool to identify the concentration change of the biochemical components in vivo and provide complementary information to the routine MR imaging contrasts.

The gagCEST-MRI technique is based on the asymmetry in the z-spectrum between the 1 ppm offset (referenced to the bulk water frequency) where GAG hydroxyl protons resonate and the reference site at − 1 ppm. Although the magnetic field inhomogeneity is a common problem for CEST imaging [29], [30], the 1 ppm site where the gagCEST effect appears is much closer to the water resonance (0 ppm) than other targeted frequencies, such as 3.5 ppm where the amide proton transfer (APT) is assessed [31], [32], [33], [34], [35], [36], [37]. The small chemical shift difference makes it harder to distinguish the CEST effect from direct water saturation. The frequency shift even as small as 0.1 ppm in the z-spectrum is able to cause a dramatic change in the quantification of the GAG concentration. A B0 correction is always necessary in the image post-processing stage. The conventional approach for this is to acquire saturation images over a range of frequency offsets with a fine frequency interval [29], [30]. Then, the whole z-spectrum is assessed by the high order polynomial fit and the B0 map is obtained by looking for the lowest signal intensity in the spectrum (z-spectrum method). However, this scan requires a fairly long scan time (2–3 min) for a single slice due to the necessary sweep of the RF saturation frequency offsets. On the other hand, it is well known that a B0 map can be acquired with the gradient echo method [38]. This scan requires much shorter time (usually less than 40 s) and is easy to be implemented on clinical scanners. The gradient echo method has been used in CEST imaging by several researchers [39], [40], [41]. Zhao et al. have compared the gradient echo field-mapping method and the z-spectrum based water saturation shift referencing method in APT imaging of human brain tumor at 3 T, showing the comparable MTR asymmetry results [40]. Dula et al. evaluated the high order polynomial fit and gradient echo B0 mapping approaches in CEST imaging of brain at 7 T [41]. However, no previous study has been performed to quantitatively evaluate the performance of the gradient echo B0 mapping methods with different echo times (TEs) and their effects on the gagCEST imaging. The purpose of this study is to examine and improve B0 field inhomogeneity corrections in knee gagCEST imaging using the dual gradient echo B0 mapping method. The widely used z-spectrum method was used as a standard reference in the study.

Section snippets

Study design and population

Eleven clinical patients (age, 36 ± 9 years) were referred for 3 T MR imaging of the knee from July to September 2010. The reason to include clinical patients is to vary the endogenous local environment around the cartilage area among each individual case which helps broaden the observed local B0 field homogeneity range. Three healthy volunteers (age, 25 ± 3 years) without known knee problems were also enrolled in this study. Bilateral knees were scanned for the volunteers and the single diseased knee

Healthy volunteer studies

The average B0 shifts in the patellofemoral compartments (n = 6) from all volunteers are: 0.18 ± 0.09 ppm using the z-spectrum method; 0.18 ± 0.09 ppm using the dual gradient echo method (∆TE = 10 ms); 0.19 ± 0.10 (∆TE = 8 ms); 0.18 ± 0.10 (∆TE = 4 ms); 0.17 ± 0.10 (∆TE = 2 ms); and 0.18 ± 0.09 (∆TE = 1 ms). The average MTRasym(1 ppm) values using the z-spectrum method were measured to be 2.10% ± 0.33%; using the dual gradient echo method to be 2.05% ± 0.56% (∆TE = 10 ms); 1.58% ± 1.02% (∆TE = 8 ms); 2.24% ± 1.62% (∆TE = 4 ms); 2.58% ± 1.89%

Discussion

The GAG concentration in cartilage plays an important role in diagnosing early stages of OA and tracking the OA progression. The clinical assessment of cartilage is generally based on the local signal changes caused by synovial fluid leaking into fissures, and morphological changes. This assessment tends to neglect cartilage alterations at the molecular level. The current GAG imaging gold standard-dGEMRIC requires contrast agent injection and patient exercise to help the contrast agent diffuse

Acknowledgments

This study was supported in part by Wright Center of Innovation in Biomedical Imaging and OSU medical center imaging signature program and grants from the National Institutes of Health (R21CA156945, R01EB009731).

References (44)

  • I. Watt

    Osteoarthritis revisited—again!

    Skeletal Radiol

    (2009)
  • C.F. Dillon et al.

    Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991–94

    J Rheumatol

    (2006)
  • R.C. Lawrence et al.

    Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States

    Arthritis Rheum

    (1998)
  • R.C. Lawrence et al.

    Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

    Arthritis Rheum

    (2008)
  • E. Yelin et al.

    Medical care expeditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997

    Arthritis Rheum

    (2007)
  • W.P. Chan et al.

    Osteoarthritis of the knee: comparison of radiography, CT, and MR imaging to assess extent and severity

    AJR Am J Roentgenol

    (1991)
  • J.P. Raynauld et al.

    Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes

    Arthritis Res Ther

    (2006)
  • Y. Emad et al.

    Can magnetic resonance imaging differentiate undifferentiated arthritis based on knee imaging?

    J Rheumatol

    (2009)
  • F. Eckstein et al.

    Imaging of knee osteoarthritis: data beyond the beauty

    Curr Opin Rheumatol

    (2007)
  • K. Subburaj et al.

    The acute effect of running on knee articular cartilage and meniscus magnetic resonance relaxation times in young healthy adults

    Am J Sports Med

    (2012)
  • N.M. Menezes et al.

    T2 and T1rho MRI in articular cartilage systems

    Magn Reson Med

    (2004)
  • E.M. Shapiro et al.

    23Na MRI accurately measures fixed charge density in articular cartilage

    Magn Reson Med

    (2002)
  • Cited by (39)

    • gagCEST imaging at 3 T MRI in patients with articular cartilage lesions of the knee and intraoperative validation

      2021, Osteoarthritis and Cartilage
      Citation Excerpt :

      In our scanning approach, center frequency adjustment aimed for calibrating the transmitter frequency to the water frequency within cartilage tissue. Residual small B0 offsets were then accounted for using B0 correction following the z-spectrum method according to the findings described by Wei et al.11. The post-processing was performed using in-house-modified software (Matlab 7, the Mathworks, Naticks, MA, USA).

    • Pros and cons of ultra-high-field MRI/MRS for human application

      2018, Progress in Nuclear Magnetic Resonance Spectroscopy
    • A Phase I clinical trial of the knee to assess the correlation of gagCEST MRI, delayed gadolinium-enhanced MRI of cartilage and T2 mapping

      2017, European Journal of Radiology
      Citation Excerpt :

      The saturation pulses consisted of a train of 16 continuous rectangular RF pulses simulating block pulse with a total duration of 2 s and saturation power of 1.2 μT. The gagCEST protocol was generally consistent with our previous study, except with a longer duration of saturation pre-pulse [32]. One image without saturation pre-pulse was acquired for the signal normalization.

    • A narrative overview of the current status of MRI of the hip and its relevance for osteoarthritis research – what we know, what has changed and where are we going?

      2017, Osteoarthritis and Cartilage
      Citation Excerpt :

      Regional differences in T2 relaxation time resulting from normal spatial variation of the cartilage matrix must be kept in mind when employing this technique43, as they can make the diagnosis of cartilage degeneration more difficult8. Additionally, the orientation of the articular surface relative to the static magnetic field (B0) results in higher T2 values near the “magic angle” of 54.7° relative to B046. T2* mapping can be performed using 3D techniques and is faster than T2 mapping due to the long echo train lengths necessary to accurately characterize the T2 cartilage signal decay47.

    View all citing articles on Scopus
    View full text